Identification of new cancer stem cell markers and signaling pathways in HER-2-positive breast cancer by transcriptome sequencing

Human epidermal growth factor receptor (HER)-2-positive breast cancer accounts for ~25% of all breast cancer cases, has a high propensity for relapse, metastasis and drug resistance, and is associated with a poor prognosis. Therefore, it is necessary to develop more effective therapeutic targets for...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Lu, Huang, Shangke, An, Gaili, Wang, Guanying, Gu, Shanzhi, Zhao, Xinhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776190/
https://www.ncbi.nlm.nih.gov/pubmed/31545416
http://dx.doi.org/10.3892/ijo.2019.4876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776190/
https://www.ncbi.nlm.nih.gov/pubmed/31545416
http://dx.doi.org/10.3892/ijo.2019.4876

Ejemplares similares